HopeStage
Back to all studies
CompletedNCT07621731

A Pragmatic, Pathway-Stratified Cluster-Waitlist-Controlled study of Three Variants of Resilience-Oriented Therapy in Rwanda

It tested Resilience-Oriented Therapy - Emotion-Regulation Variant for Mental Health; Psychological Trauma; PTSD; Depression; Anxiety; Aggression; Substance-related Disorders; Psychosocial Functioning.

PTSD, Addiction, ...BehavioralOver 18 Years
The study in practice

Understand this study

Who was this study for?

Listed age limits: from 18 years.

Listed locations
Ngoma, Rwanda · Nyagatare, Rwanda and 3 more locationsSee all locations and recruitment

Compensation and expense reimbursement have not been verified for this summary.

Study clarity

Study information

Study start dateStarted: April 28, 2023
Recruitment status
Completed
Enrollment listed in the registry
427
Sponsor
Alexandros Lordos, PhD
Sponsor type
Individual investigator
Study type
Behavioral
Intervention type
Psychotherapy / behavioral intervention
Study phase
Not clearly listed
Locations
Rwanda
Age range
Over 18 Years
Official registry ID
NCT07621731
Official title
A Pragmatic, Pathway-Stratified Cluster-Randomized Waitlist-Controlled Trial of Three Variants of Resilience-Oriented Therapy in Rwanda

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Ngoma · Nyagatare · Ruhengeri

2 more locations
  • Nyamagabe
  • Nyabihu
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Alexandros Lordos, PhD.

Who was this study for?

Listed age limits: from 18 years.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me